Evogene Market Cap

Evogene has a market cap or net worth of $9.9 million as of January 8, 2026. Its market cap has increased by 11.59% in one year.

Market Cap

9.90M

Enterprise Value

12.68M

1-Year Change

11.59%

Ranking

#5164

Market Cap Chart

Since October 15, 2007, Evogene's market cap has decreased from $28.02M to $9.90M, a decrease of -64.67%. That is a compound annual growth rate of -5.54%.

Market Cap History

Date	Market Cap	% Change
Jan 8, 2026	9.90M	20.43%
Dec 31, 2025	8.22M	-36.78%
Dec 31, 2024	13.00M	-69.10%
Dec 31, 2023	42.08M	60.85%
Dec 29, 2022	26.16M	-63.27%
Dec 30, 2021	71.23M	-58.31%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	989.63B
Johnson & Johnson	499.88B
AbbVie	402.59B
UnitedHealth Group	311.97B
AstraZeneca	293.89B
Merck & Co.	276.17B
Novartis AG	268.87B
Novo Nordisk	253.02B

Market Cap Rankings